NovaBay Pharmaceuticals signs deal with ALLDocs Optometry Group

ALLDocs, also known as The Association of LensCrafters Leaseholding Doctors, is the second largest independent optometry group in the U.S. It works closely with its LensCrafters partners.

"This agreement with ALLDocs will bring Avenova to hundreds of additional optometrists and thousands of additional patients," said Glenn Moro, VP Sales & Marketing for Avenova at NovaBay. "It also demonstrates how demand for Avenova is growing among optometrists as they learn about the many benefits the product brings to patients."

Combined with NovaBay’s previous distribution agreements with McKesson Corporation, Cardinal Health, AmerisourceBergen and Vision Source, the largest independent optometry network in the U.S. , the new agreement means that Avenova now will be available in thousands of optometrist and ophthalmologist offices across the country, in addition to the majority of the nation’s 67,000 pharmacies and many retail chains.

NovaBay president and CEO Ron Najafi said: "This agreement certainly has the potential to increase Avenova sales.

"More importantly, the impact of the agreement will be that more patients suffering from chronic and often-painful eye conditions like blepharitis will finally be able to find relief."

Avenova is the only lid hygiene product that contains Neutrox, NovaBay’s proprietary pure hypochlorous acid, which mimics a naturally occurring substance produced by white blood cells to fight microbial invaders.

Lab tests show that Neutrox is effective in solution both at killing microbes and at neutralizing bacterial enzymes and toxins. Those properties enable Avenova to help in the management of blepharitis and other common eye conditions like meibomian gland dysfunction. Indeed, both patients and doctors report that a regimen of daily lid hygiene using Avenova has been remarkably successful in managing those conditions.